IKBKG and colitis: This possibility was illustrated by recent transplant experience with Nuclear Factor κB Essential Modulator (NEMO) defects, in which HSCT appeared to correct the function of immune cells but not of intestinal epithelial cells, accounting for the persistence of colitis after transplant in some patients and the new onset of colitis post-HSCT in others [12].